Additionally, hsa-miR-125b and hsa-miR-155 are related to tumor staging, invasion degree, and EGFR expression, potentially playing a role not only in prognostic evaluation but also in guiding EGFR-targeted therapy [57,58]. The gene discussed is EGFR; the disease is neoplasm.